undefined
EUTM file information

018241383

FARON


May 18, 2020

Trademark Summary

The trademark FARON was filed by Faron Pharmaceuticals Oy, a corporation established under the laws of the Republic of Finland (the "Applicant"). The application was published for oppositions on June 8, 2020, and received one opposition filed on September 6, 2020 by Zentiva, k.s. on Likelihood of confusion. the opponent was represented by C|K|T ČERVENKA TURKOVÁ & PARTNERS PATENT, TRADEMARK AND LAW OFFICE and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 6, 2020

The application was filed in Finnish, and Finnish was also language of all opposition proceedings (English was selected as the second language).

Cancellation Proceedings

A total of undefined cancellation proceedings were initiated against the trademark registration in 2021.The first Cancellation was filed by Fagron BV (represented by NLO SHIELDMARK B.V.) on July 9, 2023 and Final decision on costs – Request withdrawn.

Application for revocation or for a declaration of invalidity of the trademark registration was recorded on December 5, 2021. Decisions on applications for revocation or for a declaration of invalidity of the trademark registration was recorded on July 13, 2023. Partial Surrender of the trademark registration was recorded on July 31, 2023.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceuticals for treatment of diseases and disorders of blood and blood forming organs
    2. Pharmaceutical preparations for treatment and prevention of ischemic conditions, inflammations and organ damages resulting from tissue traumas, reperfusion injuries, cancer, cancer metastasis, inflammatory conditions and allergic conditions
    3. Pharmaceutical preparations for the treatment of cancer
    4. Vaccine adjuvants
    5. Antibodies
    6. Biopharmaceuticals for the treatment of cancer
    7. Pharmaceutical preparations for the treatment of immune system related diseases and disorders.
  • The mark was filed in class 42 with following description of goods:
    1. Pharmaceutical research and development
    2. Development of pharmaceutical preparations and medicines
    3. Clinical trials
    4. Medical research.